Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Kuhn

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Plos One|April 29, 2011
Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosisRebecca Craig-Schapiro, Max Kuhn, Chengjie Xiong, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 7, 2010
Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntington's diseaseRobin J Kleiman, Lida H Kimmel, Susan E Bove, et al.
Plos One|November 11, 2011
Modeling the mechanism of action of a DGAT1 inhibitor using a causal reasoning platformAhmed E Enayetallah, Daniel Ziemek, Michael T Leininger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 12, 2017
Leveraging of Rifampicin-Dosed Cynomolgus Monkeys to Identify Bile Acid 3-O-Sulfate Conjugates as Potential Novel Biomarkers for Organic Anion-Transporting PolypeptidesRhishikesh Thakare, Hongying Gao, Rachel E Kosa, et al.
Acta Neuropathologica|March 17, 2010
Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairmentWilliam T Hu, Alice Chen-Plotkin, Steven E Arnold, et al.
Archives of Neurology|July 18, 2012
Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer diseaseHolly D Soares, William Z Potter, Eve Pickering, et al.
Patterns (New York, N.Y.)|January 29, 2021
SIMON: Open-Source Knowledge Discovery PlatformAdriana Tomic, Ivan Tomic, Levi Waldron, et al.
Neurology|August 3, 2012
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer diseaseWilliam T Hu, David M Holtzman, Anne M Fagan, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Plos One|April 29, 2011
Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosisRebecca Craig-Schapiro, Max Kuhn, Chengjie Xiong, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 7, 2010
Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntington's diseaseRobin J Kleiman, Lida H Kimmel, Susan E Bove, et al.
Plos One|November 11, 2011
Modeling the mechanism of action of a DGAT1 inhibitor using a causal reasoning platformAhmed E Enayetallah, Daniel Ziemek, Michael T Leininger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 12, 2017
Leveraging of Rifampicin-Dosed Cynomolgus Monkeys to Identify Bile Acid 3-O-Sulfate Conjugates as Potential Novel Biomarkers for Organic Anion-Transporting PolypeptidesRhishikesh Thakare, Hongying Gao, Rachel E Kosa, et al.
Acta Neuropathologica|March 17, 2010
Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairmentWilliam T Hu, Alice Chen-Plotkin, Steven E Arnold, et al.
Archives of Neurology|July 18, 2012
Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer diseaseHolly D Soares, William Z Potter, Eve Pickering, et al.
Patterns (New York, N.Y.)|January 29, 2021
SIMON: Open-Source Knowledge Discovery PlatformAdriana Tomic, Ivan Tomic, Levi Waldron, et al.
Neurology|August 3, 2012
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer diseaseWilliam T Hu, David M Holtzman, Anne M Fagan, et al.
Pageof 3